Literature DB >> 562143

Persistent infection of BHK21/WI-2 cells with rubella virus and characterization of rubella variants.

M Sato, H Tanaka, T Yamada, N Yamamoto.   

Abstract

Persistently infected cell lines of BHK21/WI-2 cells have been established by infection with the wild type rubella virus strain M-33. These cell lines, BHK-MP1 and BHK-MP2, showed immunity-like resistance to superinfection with M-33 virus at both 34 degrees and 39.5 degrees C. They also showed intrinsic interference with the replication of Newcastle Disease Virus at 34 degrees C but not at 39.5 degrees C. They released a small number of infectious virus particles which were temperature sensitive variants, being able to form plaques at 34 degrees C, but not at 39.5 degrees C on BHK21/WI-2 and on its derivative, BSR. When BHK-MP1 cells were cultured at 34 degrees C in growth medium containing 10--20 microgram/ml of 5-bromodeoxyuridine (BudR) there was a 5- to 10-fold increase in infectious virus in the medium as compared with the untreated controls. Mitomycin C (0.5 microgram/ml) treatment for 7 hours likewise stimulated the release of virus from these cells. The enhancement of viral release by BudR was completely blocked by pretreatment with actinomycin D (5 microgram/ml) for 3 hours prior to BudR treatment. Since the variant can be induced by these prophage inducers and inhibited by actinomycin D it is suggested that the viral genome is converted to a DNA provirus which is analogous to the lysogenic state of bacteriophage.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562143     DOI: 10.1007/bf01314778

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Recovery of rubella virus from army recruits.

Authors:  P D PARKMAN; E L BUESCHER; M S ARTENSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

2.  Plaque formation of herpes virus hominis type 2 and rubella virus in variants isolated from the colonies of BHK21/WI-2 cells formed in soft agar.

Authors:  M Sato; N Maeda; H Yoshida; M Urade; S Saito
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Hemadsorption-negative plaque test: new assay for rubella virus revealing a unique interference.

Authors:  P I Marcus; D H Carver
Journal:  Science       Date:  1965-08-27       Impact factor: 47.728

4.  Rubella antibody in IgG and IgM immunoglobulins detected by immunofluorescence.

Authors:  S M Cohen; C P Ducharme; C A Carpenter; R Deibel
Journal:  J Lab Clin Med       Date:  1968-11

5.  Recovery of infectious proviral DNA from mammalian cells infected with respiratory syncytial virus.

Authors:  R W Simpson; M Iinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  Some properties of temperature-sensitive mutant of rubella virus defective in the induction of interference to Newcastle disease virus.

Authors:  K Mifune; S Matsuo
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

7.  Integration of viral genomes.

Authors:  V M Zhdanov
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

8.  Evidence for hybrid formation between rubella virus and a latent virus of BHK21/WI-2 cells.

Authors:  M Sato; T Yamada; K Yamamoto; N Yamamoto
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

9.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  9 in total
  23 in total

1.  Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening.

Authors:  Mohamad Aljofan; Simon Saubern; Adam G Meyer; Glenn Marsh; Joanne Meers; Bruce A Mungall
Journal:  Virus Res       Date:  2009-01-29       Impact factor: 3.303

2.  Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples.

Authors:  Justine Cheval; Virginie Sauvage; Lionel Frangeul; Laurent Dacheux; Ghislaine Guigon; Nicolas Dumey; Kevin Pariente; Claudine Rousseaux; Fabien Dorange; Nicolas Berthet; Sylvain Brisse; Ivan Moszer; Hervé Bourhy; Claude Jean Manuguerra; Marc Lecuit; Ana Burguiere; Valérie Caro; Marc Eloit
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

3.  Persistent infection of primary human cell cultures with rubella variant carrying DNA Polymerase activity.

Authors:  N Sato Mmaeda; N Maeda; M Urade; M Kuribayashi; K Shirasuna; H Yoshida; T Miyazaki
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

4.  Isolation and characterization of a new rubella variang with DNA polymerase activity.

Authors:  M Sato; M Urade; N Maeda; T Miyazaki; M Watanabe; T Shibata; N Yamamoto
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.

Authors:  René G P van Gennip; Sandra G P van de Water; Christiaan A Potgieter; Piet A van Rijn
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture.

Authors:  Mathilde L Schade-Weskott; Antoinette van Schalkwyk; J J O Koekemoer
Journal:  Virus Genes       Date:  2018-05-05       Impact factor: 2.332

7.  Search for viral nucleic sequences in rheumatoid cells.

Authors:  M Norval; C Smith
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

8.  Genetic modification of Bluetongue virus by uptake of "synthetic" genome segments.

Authors:  René G P van Gennip; Daniel Veldman; Sandra G P van de Water; Piet A van Rijn
Journal:  Virol J       Date:  2010-10-07       Impact factor: 4.099

9.  The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread.

Authors:  Rojjanaporn Pulmanausahakul; Jianwei Li; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.

Authors:  Piet A van Rijn; Mieke A Maris-Veldhuis; René G P van Gennip
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.